Search - tctmd.com

Displaying 61 - 80 of 254

Sort: Relevancy | Date

Presentation TCT 2022

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Presenter: David Cohen

September 17, 2022

Presentation TCT 2022

Physiologic and Hemodynamic Parameters Influencing Device Selection and Clinical Outcomes

Presenter: Neil Fam

September 17, 2022

Presentation TCT 2022

To Repair or Replace: A Treatment Algorithm Derived from Multimodality Imaging

Presenter: Rebecca Hahn

September 17, 2022

Presentation TCT 2022

Transcatheter Tricuspid Valve Intervention: Anatomical and Technological Challenges

Presenter: Thomas Modine

September 17, 2022

Presentation TCT 2022

Definining the Appropriate Patients for TTVI: What Have We Learned From Surgery

Presenter: Robert Smith

September 17, 2022

Presentation TCT 2022

Advances in Transcatheter Therapy for SMR: Imaging Evolution, Ventricular Remodeling, and Emerging Devices

Presenter: Azeem Latib

September 17, 2022

News Conference News TCT 2022

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Caitlin E. Cox

September 17, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

News Conference News TCT 2021

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Caitlin E. Cox

November 06, 2021

News Conference News TCT 2021

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

Todd Neale

November 06, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

L.A. McKeown

November 05, 2021

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Todd Neale

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

Presenter: William Abraham

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Advertisement

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Physiologic and Hemodynamic Parameters Influencing Device Selection and Clinical Outcomes

To Repair or Replace: A Treatment Algorithm Derived from Multimodality Imaging

Transcatheter Tricuspid Valve Intervention: Anatomical and Technological Challenges

Definining the Appropriate Patients for TTVI: What Have We Learned From Surgery

Advances in Transcatheter Therapy for SMR: Imaging Evolution, Ventricular Remodeling, and Emerging Devices

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content